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TNFαTNFα can promote either cell survival or cell death. The activation of NF-κB plays a central role in cell survival
while its inhibition makes TNFα-triggered cytotoxicity possible. Here, we report that the overexpression of a
non-degradable mutant of the inhibitor of NF-κB (super-repressor (SR)-IκBα) sensitizes HeLa cells towards
TNFα-induced apoptosis, involving caspases activation and cytocrome C release from the mitochondria. In-
terestingly, we describe that the speciﬁc knockdown of Bcl-xL, but not that of Bcl-2, Bcl-w or Mcl-1, renders
cells sensitive to TNFα-induced apoptosis. This cytotoxic effect occurs without altering the activation of
NF-κB. Then, the activation of the NF-κB pathway is not sufﬁcient to protect Bcl-xL-downregulated cells
from TNFα-induced cell death, meaning that TNFα is not able to promote cell survival in the absence of
Bcl-xL. In addition, Bcl-xL silencing does not potentiate the cytotoxicity afforded by the cytokine in
SR-IκBα-overexpressing cells. This indicates that TNFα-induced apoptosis in SR-IκBα-overexpressing cells
relies on the protein levels of Bcl-xL. We have corroborated these ﬁndings using RD and DU-145 cells,
which also become sensitive to TNFα-induced apoptosis after Bcl-xL knockdown despite that NF-κB remains
activated. Altogether, our results point out that the impairment of the anti-apoptotic function of Bcl-xL should
make cells sensitive towards external insults circumventing the TNFα-triggered NF-κB-mediated
cytoprotective effect. Hence, the speciﬁc inhibition of Bcl-xL could be envisaged as a promising alternative
strategy against NF-κB-dependent highly chemoresistant proliferative malignancies.
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TNFα can trigger two opposite biological effects, promoting either
cell survival or cell death [1]. Cell survival is directly correlated with a
strong activation of NF-κB, whereas cell death occurs when this tran-
scription factor results poorly engaged. Therefore, it is well known
that a simultaneous inhibition of NF-κB is required to allow TNFα-
mediated cytotoxicity [2–4]. Several genes that are upregulated by
NF-κB, such as IAPs, play cytoprotective roles by avoiding apoptosis
through different mechanisms including caspases activation inhibition
[5]. Most of cells that exhibit resistance to TNFα-mediated cell death be-
long to ‘type II cells’, in which the release of pro-apoptogenic factors
from the mitochondria is required to amplify the cytotoxic intracellular
cascade [6]. Given that NF-κB is able to prevent cell death and that
TNFα-triggered cytotoxicity needs the cooperation of mitochondrial
pro-apoptogenic factors, the activation of this transcription factor and
the repression of mitochondria-related apoptotic events might be
1086 E. Casanelles et al. / Biochimica et Biophysica Acta 1833 (2013) 1085–1095interconnectedmolecular clues [7]. Nonetheless, there are no conclusive
reports addressing the individual contribution of each anti-apoptotic
member of the Bcl-2 family on NF-κB-mediated TNFα-triggered cell
survival.
The aim of the present study was, therefore, to unravel the mecha-
nisms underlying TNFα-mediated cell death in a background where
NF-κB was indeed inhibited. We demonstrate that the expression of a
super-repressor of NF-κB (SR-IκBα) sensitizes HeLa cells towards apo-
ptosis, but not necroptosis, induced by TNFα. We also show that this
process involves both the activation of caspases and the release of
cytocrome C from the mitochondria. The speciﬁc knockdown of each
anti-apoptotic member of the Bcl-2 family unravels a speciﬁc and
non-redundant role of Bcl-xL, which regulates the TNFα-mediated
switch between cell survival and cell death without affecting NF-κB
activation. In this context, we show that the silencing of Bcl-xL does
not impair TNFα-mediated cIAP-2 upregulation, a well-known NF-κB
gene target. Furthermore, Bcl-xL knockdown does not raise the number
of apoptotic nuclei in SR-IκBα-transformed cells after TNFα challenge.
Finally, we expand these results to other kinds of tumoral cells such as
RD and DU-145. We show that both become sensitive to TNFα when
Bcl-xL is downregulated without affecting NF-κB activation. Altogether,
our results suggest that NF-κB cannot exert its protective role if Bcl-xL
function is impaired even though its transcriptional function remains
unaltered.
2. Materials and methods
2.1. Reagents and cell culture
Recombinant human TNFα (CYT-223) was obtained from AbBcn S. L.
(Barcelona, Spain). The pan-caspase inhibitor q-VD-OPh was from
MPBiomedicals Europe (Illkirch, France). The inhibitor of necroptosis,
Necrostatin-1, was from Sigma. The ﬂuorogenic caspase substrate Ac-
DEVD-afc was from Calbiochem (San Diego, CA). Antibodies anti-IκB
(C-21) (sc-371), anti-cIAP-2 (sc-7944) and anti-RelA/p65 NF-κB subunit
(sc-372) were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Antibodies against cytocrome C (556433), pro-caspase-8 (551242),
Bcl-xL (610211), and panERK (612641) were from BD Biosciences (San
Diego, CA). Anti-pro-caspase-3 antibody (9662) was from Cell Signaling
Technology (Beverly, MA). Anti-pro-caspase-9 antibody (clone 5B4)
(M-054-3) was from MBL (Naka-ku Nagoya, Japan). Anti-p23 (JJ3)
(NB300-576) was from Novus Biologicals (Cambridge, UK). Anti-Bcl-2
(M0877) was from DAKO (Glostrup, Denmark). Anti-Bcl-w (AM54)
was from Calbiochem (La Jolla, CA). Anti-Mcl-1 (M8434) was from
Sigma-Aldrich (St Louis, MO). Unless otherwise indicated, all reagents
were from Sigma-Aldrich.
2.2. Cell culture
HeLa (human cervix adenocarcinoma) and RD (human embryonal
rhabdomyosarcoma) cells were cultured in DMEM (Invitrogen), and
DU-145 (human prostate carcinoma) in MEM (Invitrogen). For all
cell types, the culture media were supplemented with 10% heat-
inactivated FBS, 20 units/mL penicillin and 20 μg/mL streptomycin
and 1% of non-essential amino acids (Invitrogen). Cells were grown
at 37 °C in a humidiﬁed atmosphere of 5% CO2.
2.3. Plasmids
The NF-κB-dependent reporter vector (HIV-LTR-Luciferase) and
SR-IκBα cDNA [8] were obtained from R. Hay (University of St.
Andrews, Fife, Scotland). For transient overexpressions, pcDNA3-IκBα
super-repressor (SR-IκBα), pcDNA3-human Bcl-xL or pcDNA3-empty
vectors [9,10] were transfected in HeLa cells by using Lipofectamine
2000 Reagent (Invitrogen) according to manufacturer's instructions.
Additionally, pcDNA3-SR-IκB or pcDNA3-empty transfected cells wereselected for a month in the presence of 1 mg/mL G-418 (Invitrogen)
and used as a pool. The efﬁcient SR-IκBα and/or Bcl-xL overexpressions
were assessed by Western blot analysis.
2.4. siRNAs transfection
siRNA transfection was carried out with Oligofectamine™ 2000
Transfection Reagent (Invitrogen) as indicated by the manufacturer.
For Caspase-8, a mixture of two siRNAs was used. The sequences of
the siRNAs were: 5′-CAGGCGACGAGUUUGAACU-3′ (siBcl-xL); 5′-GGU
UUGGCAUAUCUAAUAA-3′ (siMcl-1); 5′-GGAUCAUGCUGUACUUAAA-3′
(siBcl-2); 5′-UGAGGAAGGUGGACUUACA-3′ (siBcl-w); 5′-GAAUGUUGG
AGGAAAGCA-3′, 5′-ACAUGAACCUGCUGGAUAU-3′ (siCaspase-8) and
5′-AUAUGCGAUCGAGAUAUCG-3′ (nonsense).
2.5. Preparation of cytosolic extracts
Cytosolic extracts were performed as previously described [11]with
some modiﬁcations. Brieﬂy, cells were collected and centrifuged at
200 ×g for 5 min, rinsed in ice-cold PBS (pH 7.2), resuspended in 5 vol-
umes of cytosolic extraction buffer (70 mMSucrose, 220 mMMannitol,
5 mMHEPES-KOHpH7.2, 10 mMKCl, 2 mMMgCl2, 5 mMEDTA, 5 mM
EGTA, 0.025% Digitonine, 1 mM PMSF, 1 mM DTT), shortly vortexed
and swelled at 4 °C for 5 min. The lysates were centrifuged for 5 min
at 600 ×g in a bench microcentrifuge at 4 °C and the supernatants
were collected and quantiﬁed by the Bio-Rad protein assay Lowry-
based method.
2.6. Protein extractions and Western blots
After the different treatment conditions, cellswere rinsed in ice-cold
PBS (pH 7.2). Cells were lysed in a lysis buffer containing 2% SDS and
125 mM Tris (pH 6.8), heated at 95 °C during 10 min and protein con-
centration was quantiﬁed using a modiﬁed Lowry assay (Bio-Rad
Dc protein assay). Cell lysates (25 μg of protein) were resolved on
SDS/PAGE gels and transferred to an Immobilon-P™ PVDF transfer
membrane (Millipore). After blocking with Tris-buffered saline/0.1%
Tween-20 containing 5% non-fat dry milk for 1 h at room temperature,
membranes were probed with the appropriated primary antibodies
according to the speciﬁc requirements indicated by each provider.
After 1 h of incubationwith the speciﬁc peroxidase-conjugated second-
ary antibodies, themembraneswere developedwith the EZ-ECL chemi-
luminescence detection kit (Biological Industries).
2.7. Cell death measurements
Nuclear staining with bis-benzimide of Hoechst 33258 was
performed as previously described [12]. Uniformly stained nuclei
were scored as healthy viable cells, whereas condensed or fragmented
nuclei were scored as dead cells (apoptotic nuclear morphology).
2.8. Caspase activity
Quantitative caspase-like activities in cell lysates were performed as
previously described with minor modiﬁcations [13]. Brieﬂy, after the
indicated treatments, cells were collected and cytosolic extracts were
prepared as detailed above. Assays were performed using 20 μg of pro-
tein in the speciﬁc buffer containing 100 mM Tris (pH 7.2–7.4), 4 mM
EDTA, 4 mM EGTA, 20% sucrose, 10 mM dithiothreitol, 1 mM PMSF
plus 40 μM of the ﬂuorogenic substrate Ac-DEVD-afc. The resulting
96-multiwell microplates were incubated at 35 °C, and caspase activity
wasmeasured after 8 h of incubation in a BIO-TEK Synergy HT ﬂuorime-
ter with an excitation ﬁlter of 360 nm (40-nm bandwidth) and emission
ﬁlter of 530 nm (25-nm bandwidth). For each condition, triplicates of
each sample were done.
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Fig. 1. SR-IκBα sensitizes HeLa cells to TNFα-induced cell death by activating the intracellular apoptotic signaling. HeLa cells were transfected with pcDNA3-empty (Neo) or
pcDNA3-SR-IκBα (SR or SR-IκBα). (A) Total protein lysates were analyzed by Western blot using an antibody against IκBα. The membrane was stained with naphthol blue (NB)
to assess equal loading. (B) Neo (white bars) or SR-IκBα (black bars) cells were left untreated (−) or treated (+) with 100 ng/mL TNFα and/or 10 μM Necrostatin-1 (Nec-1) or
20 μM q-VD-OPh (QVD) for 24 h. Percentage of cell death was obtained by counting apoptotic vs total nuclei after Hoechst 33258 staining. (C) Representative pictures showing
apoptotic nuclear morphology after Hoechst staining (arrowheads). (D–E) Cytosolic extracts obtained from Neo or SR-IκBα cells were left untreated (−) or treated (+) with
100 ng/mL TNFα or 100 ng/mL TNFα plus 20 μM q-VD-OPh. (D) Pro-caspase-3 processing in its active fragment, caspase-mediated cleavage of p23 and cytocrome C release
were analyzed by Western blot. (E) Caspase-3-like activities were measured using the ﬂuorogenic Ac-DEVD-afc reagent. ** Pb0.005.
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Fig. 2. The knockdown of Bcl-xL, but not that of Mcl-1, Bcl-2 or Bcl-w, sensitizes HeLa cells
to apoptosis triggered by the activation of either the extrinsic or the intrinsic pathways.
HeLa cells were transfected with or without (w/o) a short interfering RNA sequence
(siRNA) targeting human Bcl-xL (Bcl-xL siRNA), human Mcl-1 (Mcl-1 siRNA), human
Bcl-2 (Bcl-2 siRNA), human Bcl-w (Bcl-w siRNA) or a nonsense sequence (Ns siRNA) for
3 days. (A) Total protein lysates were obtained from untreated (−) or treated (+) cells
with 100 ng/mL TNFα for 24 h. Protein levels of Bcl-xL, Mcl-1, Bcl-2 and Bcl-w were ana-
lyzed by Western blot, conﬁrming the speciﬁc knockdowns. The membranes were
re-blotted with an anti-panERK antibody to assess equal loading. (B) Cells were left
untreated (white bars) or treated with 100 ng/mL TNFα (black bars) or 30 μM Etoposide
(gray bars) for 24 h. Percentage of cell death was obtained by counting apoptotic vs total
nuclei after Hoechst 33258 staining. *Pb0.01.
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activity assay
The determination of NF-κB status (RelA/p65 nuclear transloca-
tion and NF-κB activity) was performed as described previously [9].
2.10. Statistical analysis
All experiments were repeated at least three times. Values are
expressed as means±SEM. Student's t-tests were used to determine
the statistical signiﬁcance in cell death measurements. P≤0.01 was
considered to be signiﬁcant.
3. Results
3.1. TNFα induces apoptosis rather than necroptosis in
SR-IκBα-overexpressing HeLa cells
HeLa cells were transfected with the super-repressor of NF-κB
(SR-IκBα-pcDNA3 (SR-IκBα)) or an empty-pcDNA3 vector (Neo)
(Fig. 1A). As shown in Fig. 1B, SR-IκBα transfection did not alter HeLa
cells viability. However, SR-IκBα overexpression rendered HeLa cells
sensitive to TNFα-mediated cytotoxicity (Fig. 1B). The cell death in-
duced by the cytokine was prevented by q-VD-OPh — a broad-range
inhibitor of caspases — but not by Necrostatin-1 — an inhibitor of
necroptosis. Accordingly, TNFα-injured SR-IκBα-overexpressing cells
shared nuclear apoptotic treats as demonstrated by staining the chro-
matin by Hoechst (Fig. 1C). Consequently, in SR-IκBα-transfected
cells, TNFα induced a proper processing of pro-caspase-3 in its active
fragment, the speciﬁc cleavage of a caspase substrate such as p23
co-chaperone and the release of cytochrome C from the mitochondria
(Fig. 1D). The addition of q-VD-OPh to the culture media abolished
TNFα-triggered apoptotic signaling (Fig. 1D). Fig. 1E conﬁrmed that
the cell death observed in SR-IκBα-overexpressing cells after TNFα
challengewas dependent on the activation of caspases. These results in-
dicated that the overexpression of SR-IκBα in HeLa cells is sufﬁcient to
allow the activation of the apoptotic pathway triggered by TNFα. More-
over, this process involved the activation of caspases and the release of
cytocrome C from the mitochondria.
3.2. The speciﬁc knockdown of Bcl-xL is sufﬁcient to render HeLa cells
sensitive towards TNFα-induced apoptosis
The fact that cytocrome C was released after TNFα treatment in
SR-IκBα-overexpressing HeLa cells (Fig. 1D), suggested that the mito-
chondrial homeostasis could play a key role in SR-IκBα-mediated sensiti-
zation to TNFα-triggered apoptosis. Bcl-2 family acts as gatekeeper
regulating the homeostasis of themitochondria. Given that HeLa cells ex-
press the four main anti-apoptotic members of the Bcl-2 family (Fig. 2A),
we wanted to assess whether the downregulation of one or several of
these could sensitize towards TNFα-mediated cytotoxicity. To this
purpose, we designed speciﬁc siRNAs against Bcl-xL (Bcl-xL siRNA),
human Mcl-1 (Mcl-1 siRNA), human Bcl-2 (Bcl-2 siRNA), and
human Bcl-w (Bcl-w siRNA). As pictured in Fig. 2A, all the siRNAs
tested proved to be efﬁcient at reducing the total protein amount
of its respective target gene without affecting the other anti-apoptotic
members of the family. Next, we wanted to assess their impact on
TNFα-mediated cytotoxicity. When compared with cells transfected
with a nonsense siRNA sequence (Ns siRNA), which did not alter the ex-
pression of the proteins studied (data not shown), the siRNA designed
against Bcl-xL was themost effective and the only statistically signiﬁcant
to sensitize cells towards TNFα-triggered apoptosis (Fig. 2B, black bars).
It has been previously reported that the degradation of Mcl-1 protein is
required to sensitize cells towards an intrinsic apoptotic stimulus such
as etoposide [14]. Since, in our experimental conditions, Mcl-1 silencing
was not as effective as Bcl-xL downregulation to sensitize cells toNFα-induced apoptosis, we wanted to ascertain whether the knock-
down of Mcl-1 was sufﬁcient to sensitize HeLa cells towards sub-
lethal concentrations of etoposide. As shown in Fig. 2B, either Bcl-xL or
Mcl-1 knockdowns sensitized cells to etoposide-induced apoptosis.
Indeed, the percentage of apoptosis induced by etoposide was 18.1
(±0.75) % and 21.4 (±0.67) % in Bcl-xL- and Mcl-1-silenced cells, re-
spectively (Fig. 2B). In this sense, HeLa cells transfected with Mcl-1
siRNA proved to be two-fold more sensitive to etoposide than to
TNFα (21.4 (±0.67) % and 11.0 (±0.50) %, respectively) (Fig. 2B).
However, the percentage of apoptotic Bcl-xL-knockdowned cells after
treatment with TNFα or etoposide was comparable (20.3 (±0.20) %
or 18.1 (±0.75) %, respectively) (Fig. 2B). Taken together, the results
obtained revealed that the decrease in Bcl-xL expression is sufﬁcient
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ment, indicating that this protein is necessary and sufﬁcient to control
HeLa behavior to this cytokine.
3.3. TNFα induces apoptosis rather than necroptosis in
Bcl-xL-downregulated HeLa cells
Once we pointed Bcl-xL as the molecular gatekeeper conferring cell
resistance against TNFα-mediated cytotoxicity, we sought to study
the mechanism by which cells demised. From now on, we used the
siRNA against Bcl-2 as a negative control siRNA since the percentages
of apoptosis observed upon TNFα stimulus where comparable toC Untreated TNF Necr-1
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Bcl-xL-downregulated cells were left untreated (−) or treated (+) with 100 ng/mL TNFα
using the ﬂuorogenic Ac-DEVD-afc reagent. * Pb0.01.those obtained with a nonsense siRNA (Ns siRNA) (Fig. 2B). Moreover,
and contrary to the Ns siRNA, we can ensure the Bcl-2 siRNA effective-
ness by analyzing the Bcl-2 protein levels byWestern blot. As shown in
Fig. 3B, in contrast to Bcl-2-downregulated cells (Fig. 3A), Bcl-xL-
silenced cells (Fig. 3A) became sensitive to TNFα-mediated cell death.
Moreover, the addition of q-VD-OPh, but not necrostatin, to the culture
media prevented TNFα-induced cell death, indicating that an apoptotic
process should be being triggered (Fig. 3B). These results were
conﬁrmed by the observation of apoptotic nuclear morphologies in
TNFα-treated cells (Fig. 3C). As expected, TNFα challenge induced
caspase-like activities that were prevented by the addition of q-VD-
OPh to the culture media in Bcl-xL-knockdowned cells (Fig. 3D). InQVD TNF /Necr-1 TNF /QVD
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tivated, protein samples from Bcl-2- or Bcl-xL-downregulated cells,
untreated or treated with TNFα, were analyzed by Western blot
(Fig. 4A and B). Once ensured the correct protein knockdown
(Fig. 4A), we observed that only Bcl-xL siRNA cells displayed a proper
processing of pro-caspase-8, pro-caspase-9, pro-caspase-3 and p23
co-chaperone, a caspase substrate, into their active fragments, as well
as the release of cytochrome C from the mitochondria after being
treated with TNFα (Fig. 4B). To know if caspase-8 is required as an up-
stream initiator caspase for TNFα-mediated cytotoxicity in Bcl-xL-
downregulated cells, we transfected HeLa cells with Bcl-2 siRNA,
Bcl-xL siRNA, caspase-8 siRNA or a combination of both Bcl-xL and
caspase-8 siRNAs (Fig. 4C). As shown in Fig. 4D, caspase-8 siRNA
completely avoids TNFα-induced cell death in Bcl-xL-downregulated
cells. Altogether, these results suggested that the silencing of Bcl-xL
sensitized cells to TNFα-triggered caspase-8-dependent apoptotic cell
death.A 
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Our results showed that either the overexpression of SR-IκBα
(Fig. 1) or the downregulation of Bcl-xL (Fig. 3) sensitized HeLa cells
to TNFα-induced apoptotic cell death. Since it has been reported
that Bcl-xL can positively modulate NF-κB pathway in glioblastoma
cells [15], we sought to study whether Bcl-xL inﬂuenced TNFα-
mediated NF-κB activation status in our cellular model. In one hand,
Fig. 5B shows that TNFα-triggered apoptosis in SR-IκBα-transfected
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(Fig. 5A). This was conﬁrmed by the observation of apoptotic nuclear
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shared intracellular pathway
In order to know the relationship between Bcl-xL- and NF-κB-
mediated cytoprotection, Bcl-xL protein levels were downregulated in
Neo- or SR-IκBα-stably transfected cells (Fig. 7A). As shown in Fig. 7B
(caspase activity) and C (percentage of apoptotic nuclei), the knockdown
of Bcl-xL did not increase the sensitivity of SR-IκBα-overexpressing
cells to TNFα-triggered apoptosis. Moreover, the nuclear morphology
observed in TNFα-treated SR-IκBα-transfected cells in which Bcl-xL has
also been downregulated, shared the same apoptotic treats as SR-IκBα-
overexpressing cells cultured in the presence of the cytokine (Fig. 7D).
3.6. TNFα-induced apoptosis occurs even though NF-κB is functional in
Bcl-xL-silenced RD and DU-145 cells
In order to validate that the phenomena of Bcl-xL being a crucial pro-
tein allowing cell survival despite of NF-κB activation is not restricted to
HeLa cells, we wanted to expand our ﬁndings to other cell types. As
shown in Fig. 8A, Bcl-xL or Bcl-2 were effectively downregulated in RD
cells. Bcl-xL siRNA, but not Bcl-2 siRNA, was able to sensitize cells to
TNFα-mediated cytotoxicity (Fig. 8C). This fact was further supported
by the observation of the nuclear apoptotic morphology (Fig. 8D).
Moreover, none of the siRNAs employed impaired NF-κB nuclear trans-
location upon TNFα treatment (Fig. 8B). The same results were found
when DU-145 cells were used. DU-145 cells do not express Bcl-2
(Fig. 8E and [17,18]). In this regard, RD cells were used as a positive con-
trol to check Bcl-2 expression (Fig. 8E) and Bcl-xL downregulation was
assessed by Western blot (Fig. 8E). Bcl-xL siRNA sensitized DU-145
cells to TNFα-mediated apoptosis, which was conﬁrmed by observing
the apoptotic nuclear morphology (Fig. 8G and H). As observed in
HeLa or RD cells, the downregulation of Bcl-xL did not impair NF-κB ac-
tivation (Fig. 8F).
Altogether, our results suggest that Bcl-xL allows cell survival even
if NF-κB is not functional and that, on the other hand, NF-κB cannot
exert its protective role if Bcl-xL function is impaired.
4. Discussion
Here,we show that either the overexpression of a super-repressor of
NF-κB (SR-IκBα) or the speciﬁc down-regulation of Bcl-xL, but not that
of Mcl-1, Bcl-w or Bcl-2, is sufﬁcient to render cells sensitive to TNFα-
triggered cytotoxicity. Moreover, Bcl-xL knockdown does not impair
the activation of NF-κB. This indicates that TNFα-mediated NF-κB acti-
vation is not enough to rescue Bcl-xL-silenced cells from apoptosis.
Interestingly, Bcl-xL downregulation on SR-IκBα overexpressing cells
has no additive sensitization effects towards TNFα-triggered cytotoxic-
ity. Overall, our ﬁndings point out that despite NF-κB is correctly acti-
vated, cells exposed to TNFα are committed to death if Bcl-xL is silenced.
Some cancers possess their own pool of secreted TNFα acting as a
NF-κB-dependent autocrine pro-survival signal. NF-κB up-regulates
anti-apoptotic molecules, such as cIAPs, normally required to maintain
cancer cells viability under an extracellular environment where TNFα
is being secreted [19]. However, NF-κB is a pleiotropic transcription
factor that is activated not only in tumor cells but also after either
physiological (e.g. T-cell selection, liver regeneration) or pathological
(e.g. defense against viral or bacterial infections) cellular stresses [16].
In addition, NF-κB plays a central role in the immune response by acti-
vatingdifferent types ofmacrophages,which are indeed amajor compo-
nent of inﬂammatory inﬁltrates in most of solid tumors [20]. Then, the
non-selective inhibition of NF-κB could trigger harmful effects in the
organism. A very promising approach should be the selective blockage
of NF-κB in the tumorwithout affecting the activity of this multifactorial
transcription factor in healthy non-tumoral cells, such as inﬁltrated
macrophages. However, and unfortunately, how to do this remains
still unclear [20]. In addition, it has been found thatmost drugs currentlyused to treat cancer patients also activate NF-κB. The chronic activation
of NF-κB induced by chemotherapeutic agents is proposed to be a side
effect that can lead to chemoresistance [21]. Therefore, pursuing alterna-
tive therapeutic strategies should be of great interest. In this sense, the
value of Smac mimetics as death inductors/sensitizers for TNFα-
secreting tumors has been recently pointed out. However, their effec-
tiveness depends on the endogenous expression of cIAPs, mainly
cIAP-2 [22]. This fact should be otherwise directly related to the individ-
ual dependence of each pool of cells to survive to TNFα by activating
NF-κB. Indeed, a non-negligible percentage of cancer cells still present
anti-apoptotic responses over Smac mimetics [23] and some tumor
cells can still survive even in the presence of both, Smac mimetics and
TNFα [19]. To explain this, it has been recently postulated that TNFα-
mediated survival signals induced by the persistent activation of NF-κB
could shift cells to a more resistant phenotype. This is based on the
fact that Smac mimetics do not impair the proper activation of the
NF-κB pathway and, therefore, cIAP-2 is still early up-regulated [22].
Likewise, we show here that the speciﬁc silencing of Bcl-xL does not im-
pede the de novo translation of c-IAP-2, indicating that NF-κB transcrip-
tional function remains unaltered and that TNFα-mediated NF-κB
activation is not enough to rescue Bcl-xL-silenced cells from apoptosis.
Indeed, TNFα-triggered apoptosis occurs as long as Bcl-xL anti-
apoptotic function results compromised, e.g. by reducing its protein
levels. Interestingly, the repression of NF-κB transcriptional activity by
SR-IκBα overexpression does not increase the percentage of apoptosis
afforded by TNFα in Bcl-xL-downregulated cells. This suggests that de
novo transcription impairment of the anti-apoptotic genes upregulated
by NF-κB does not increase cell sensitivity to TNFα-induced apoptosis
when Bcl-xL protein levels are compromised. Altogether this indicates
that NF-κB and Bcl-xL operate through a common intracellular pathway,
being the cell survival role of NF-κB dependent on Bcl-xL anti-apoptotic
function, and that Bcl-xL controls TNFα-mediated biological effect re-
gardless of NF-κB status.
The relevance of Bcl-xL, and also Mcl-1, as key anti-apoptotic mol-
ecules has already been reported. Actually, Xiaodong Wang's group
elegantly demonstrated that the elimination of both proteins, Mcl-1
and Bcl-xL, is a required prerequisite for mediating cellular apoptotic
responses under ultraviolet irradiation or etoposide insults [14]. In
this sense, it has been reported that DNA-damaging agents need the
loss/inactivation of Mcl-1 to allow the release of the BH3-only protein
Noxa. Once liberated, Noxa triggers mitochondrial dysfunction and
cell death by inhibiting Bcl-xL [24]. Therefore, the relevance of Mcl-1
degradation relies on the release of Noxa to block the anti-apoptotic
function of Bcl-xL. It is somehow clear that the inactivation of the
pro-survival role of Bcl-xL is, in any case, the key intracellular event
allowing the apoptotic signaling in injured cells. The data presented
here show that the speciﬁc down-regulation of Bcl-xL, but not that
of Mcl-1, Bcl-w or Bcl-2, is the most efﬁcient approach to render
HeLa cells sensitive towards apoptosis induced by an extrinsic stimu-
lus, such as TNFα. In addition, TNFα does not induce the degradation
of Mcl-1, indicating that Noxa is probably sequestered yet. This fact
should be of special interest since the speciﬁc impairment of Bcl-xL
function could be envisaged as a promising therapeutic tool, especial-
ly when the Mcl-1/Noxa-to-Bcl-xL axis does not work properly. In any
case, a more detailed knowledge concerning the cytotoxic counter-
parts of Bcl-xL could allow us in opening new strategies to regulate
its anti-apoptotic function in, for example, Noxa-deﬁcient malignan-
cies such as some pancreatic cancers [25]. Indeed, we could speculate
that the inhibition of Bcl-xL should liberate potential cytotoxic pro-
teins primarily sequestered by this molecule and not by Mcl-1, Bcl-2
nor Bcl-w.
Collectively, our results place Bcl-xL as the life-or-death molecular
switch modulator upon TNFα stimulus, acting independently of
both NF-κB activity and Mcl-1 protein levels. Therefore, the speciﬁc
blockade of Bcl-xL anti-apoptotic role would be of great therapeutic
interest.
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